125 related articles for article (PubMed ID: 21045388)
1. Expression of Ki67 and P53 in primary squamous cell carcinoma of the larynx.
Ashraf MJ; Maghbul M; Azarpira N; Khademi B
Indian J Pathol Microbiol; 2010; 53(4):661-5. PubMed ID: 21045388
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p63, p53 and ki67 expression in laryngeal basaloid squamous cell carcinomas.
Calli C; Calli A; Pinar E; Oncel S; Tatar B
B-ENT; 2011; 7(1):37-42. PubMed ID: 21563555
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
Calli C; Calli A; Pinar E; Oncel S; Demirtaşoğlu F
Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):9-13. PubMed ID: 16340285
[TBL] [Abstract][Full Text] [Related]
5. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
Gorban' NA; Ten VP; Pankratov VA
Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
[TBL] [Abstract][Full Text] [Related]
8. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
10. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
11. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
12. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
13. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
[TBL] [Abstract][Full Text] [Related]
14. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma.
Yuen PW; Lam KY; Choy JT; Ho WK; Wei WI
Anticancer Res; 2000; 20(6C):4863-6. PubMed ID: 11205233
[TBL] [Abstract][Full Text] [Related]
17. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors.
Nadal A; Campo E; Pinto J; Mallofré C; Palacín A; Arias C; Traserra J; Cardesa A
J Pathol; 1995 Feb; 175(2):181-8. PubMed ID: 7738713
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G
Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092
[TBL] [Abstract][Full Text] [Related]
20. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx.
Griffin MC; Robinson RA; Trask DK
Mod Pathol; 2003 Dec; 16(12):1181-8. PubMed ID: 14681317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
